Novartis Launches 3-Day Feline NSAID



Published:

Novartis Animal Health launched Onsior (robenacoxib) tablets, a three-day non-steroidal anti-inflammatory drug for postoperative cats, the Greensboro, N.C., company reported today.

The drug is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration. It is the first multidose oral NSAID to be approved for cats, Novartis reported.

The drug’s short blood half-life causes the active ingredient to be quickly eliminated from the blood while persisting longer at the site of inflamed tissue, allowing for once-a-day administration for up to three days, the company reported.

Side effects observed during a clinical field trial and six-month safety study included surgical site bleeding, infected surgery sites, lethargy, vomiting and inappetence.

The drug is indicated for cats weighing 5.5 pounds or heavier and at least 6 months old for a maximum of three days. The drug should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs and should not be administered in conjunction with any other oral or injectable NSAID or corticosteroid, according to Novartis.

 <HOME>

Archive »Read More

NCSU to Host 23nd Annual Dog Olympics Sept. 13

The aim of the event is to celebrate the human-animal bond and raise money for local animal rescue groups.

Michigan State University Co-Hosts 10th Annual Marek’s Disease Symposium

MSU and the USDA’s Avian Disease and Oncology Laboratory recently co-hosted a symposium on Marek’s disease and avian herpesvirus.

Too Many Veterinarians, or a Bubble Market?

How can a scientifically trained profession keep ignoring the facts of too many graduates chasing too few jobs with an ever increasing debt burden?

Add your comment:

Events


Show More...